[NYC session] Lessons in Herding Cats: Business Development Basics for Life Science Companies

Add this event to your calendar:
18/04/2017 12:45 18/04/2017 15:00 America/New_York [NYC session] Lessons in Herding Cats: Business Development Basics for Life Science Companies New York Genome Center , 101 6th Ave, 1st Floor , New York , NY 10013 Johnson & Johnson Innovation, JLABS false DD/MM/YYYY
April
18
Event

[NYC session] Lessons in Herding Cats: Business Development Basics for Life Science Companies

New York Genome Center , 101 6th Ave, 1st Floor , New York , NY 10013

April 18, 2017 from 12:45 PM to 15:00 PM (EST)

$10 - $35


The business development professional's purpose is to optimize optionality and long term value at each stage of a company's life. As a company grows and gains traction, it's easy to get enticed and overwhelmed by the numerous opportunities that arise. How do you determine the direction that will add the most value to your company? How do you avoid the constant pursuit of "shiny objects?" How do you know when it's the right time for a strategic partnership?

In this workshop, you'll learn fundamental business development skills to help you successfully evaluate and manage strategic alliances and other potential growth opportunities.

Topics will include:

  • Strategic alliance process management
  • Concepts in valuation
  • Importance of IP and IP diligence
  • Communication and negotiation skills
  • Basic components of a contract

This workshop is geared towards business development professionals and management teams of life science startups.

Speaker:
Lesley Stolz | Head, JLABS California, Johnson & Johnson Innovation read bio»

Agenda:
10:45 AM | Registration Opens
11:00 AM | Presentation
12:00 PM | Q&A
12:15 PM | Lunch and Networking
1:00 PM | Program Close

Fees:
$25 | General Public
$15 | Student/Academic
$35 | On site

Location:
New York Genome Center
101 6th Ave
1st floor
New York, NY
10013

Speaker's Biography:
Lesley Stolz, Ph.D. | Head, JLABS California, Johnson & Johnson Innovation, JLABS
Dr. Stolz has 20 years of business and corporate development experience working for companies that have been both technology platform and therapeutics focused. Prior to joining Johnson & Johnson Innovation, she held executive positions with BioTime, Inc., Sutro Biopharma, Inc., and Sunesis Pharmaceuticals where she was responsible for corporate strategy, fundraising and all aspects of partnering. Earlier in her career, she served as Senior Director, Business Development for Aerovance, Inc. and for GPC Biotech AG in Munich, Germany from 2002 to 2006. She also served in senior management positions at Cell Genesys, Discovery Partners International and Axys Pharmaceuticals. Dr. Stolz received her Ph.D. in chemistry, and conducted postdoctoral research at Harvard Medical School’s Department of Biochemistry and Molecular Pharmacology.
Connect with Lesley:   Connect on LinkedIn


Johnson & Johnson Innovation, JLABS

About Johnson & Johnson Innovation, JLABS Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), New York City, and with Shanghai opening in 2019. For more information please visit www.jlabs.jnjinnovation.com or follow @JLABS.

Event contact


Related content